‘People deserve to have a choice’ | Russia ‘open’ to supplying Sputnik V to EU

About This Source - RT

The video item below is a piece of English language content from RT (formerly Russia Today). RT is a Russian state-funded broadcaster.

Recent from RT:

  • Putin delivers annual address to Federal Assembly
  • Unearthed report shows Huawei may have spied on the Dutch
  • Numbers that don’t lie | Chess could make you smarter and richer – Ilya Merenzon (World Chess CEO)
  • RT published this video item, entitled “‘People deserve to have a choice’ | Russia ‘open’ to supplying Sputnik V to EU” – below is their description.

    Russia is ready to supply European nations with its Sputnik V jab as it believes people “deserve” to have a choice of vaccines but it is up to the EU to allow it, said Kirill Dmitriev, CEO of the Russian Direct Investment Fund.

    Read more: https://on.rt.com/b335

    Follow us on Telegram https://t.me/rtintl

    RT YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: Russia

    Russia, or the Russian Federation, is a transcontinental country located in Eastern Europe and Northern Asia. It extends from the Baltic Sea in the west to the Pacific Ocean in the east, and from the Arctic Ocean in the north to the Black Sea and the Caspian Sea in the south.

    Russia spans more than one-eighth of the Earth’s inhabited land area, stretching eleven time zones, and bordering 16 sovereign nations. Moscow is the country’s capital.

    The Soviet Union was dissolved in 1991 and since 1993 Russia been governed as a federal semi-presidential republic. Russia is a major great power, with the world’s second-most powerful military, and the fourth-highest military expenditure. As a recognised nuclear-weapon state, the country possesses the world’s largest stockpile of nuclear weapons.

    3 Recent Items: Russia

  • Putin, in annual address, lauds Russia’s vaccine work
  • Putin, in annual address, hails ‘breakthrough’ on Russian coronavirus vaccines
  • China, Russia and the new space race | FT
  • In This Story: Sputnik V

    Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.

    The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.

    On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.

    2 Recent Items: Sputnik V

  • Less equal? Only watchdog-approved jabs to feature on EU certificates
  • San Marino is back to pre-COVID normality – thanks to Russia’s Sputnik V
  • Leave a Comment